Avidity Partners, an investment company, led a $200m funding round in NeoGenomics, a network of clinical laboratories that specializes in cancer genetics diagnostic testing services. Additional investors include Farallon Capital Management, RS Investments, Casdin Capital, Driehaus Capital, Pura Vida Investments, RTW Investments, Janus Henderson Investors, Federated Hermes Kaufmann Fund, Soleus Capital, Blue Water Life Science Fund, Woodline Partners and First Light Asset Management.